Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA)

CUSIP: G63365103

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Ordinary shares, nominal value $0.01 per share
Shares outstanding
17,255,853
Total 13F shares
13,356,680
Share change
+13,356,659
Total reported value
$79,068,382
Price per share
$5.92
Number of holders
119
Value change
+$79,068,258
Number of buys
117

Quarterly Holders Quick Answers

What is CUSIP G63365103?
CUSIP G63365103 identifies MURA - Mural Oncology plc - Ordinary shares, nominal value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) as of Q4 2023

As of 31 Dec 2023, Mural Oncology plc - Ordinary shares, nominal value $0.01 per share (MURA) was held by 119 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,356,680 shares. The largest 10 holders included WESTFIELD CAPITAL MANAGEMENT CO LP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, BlackRock Inc., Alta Fundamental Advisers LLC, Newtyn Management, LLC, Prosight Management, LP, Bank of New York Mellon Corp, STATE STREET CORP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 119 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.